Culture Connect Featured Event

Autism/Hyperactivity Study
Ticket Price: free

Do you have a child with Pervasive Developmental Disorder and hyperactivity?

Yale Child Study Center is conducting a research study to test the effectiveness of a non-stimulant medication, extended-release guanfacine (Intuniv®), for children with PDD and hyperactivity.
 
Eligible children are at least 5 but younger than 14 years old, with autism, Asperger’s, or PDD-NOS, and clinically significant hyperactivity, currently medication-free or on ineffective medication.